Vero-Gliclazide

Vero-Gliclazide: An antidiabetic agent for the effective management of type 2 diabetes mellitus

Vero-Gliclazide is an antidiabetic drug used to treat type 2 diabetes mellitus. This drug, produced in Russia by Veropharm and the Belgorod branch, belongs to the pharmacological group of sulfonylurea derivatives.

The main active substance of Vero-Gliclazide is gliclazide. It is available in the form of tablets with a dosage of 80 mg. The drug is used both in monotherapy and in combination with insulin or other oral hypoglycemic drugs.

Vero-Gliclazide is effective in controlling blood glucose levels in patients with type 2 diabetes mellitus. It helps reduce blood sugar concentrations by stimulating insulin secretion in the pancreas and increasing tissue sensitivity to insulin.

When using Vero-Gliclazide, some contraindications must be taken into account. The drug is not recommended for hypersensitivity to gliclazide, for type 1 diabetes mellitus (including juvenile diabetes), in the presence of ketoacidosis, diabetic or hyperosmolar coma, as well as for extensive trauma and burns. Other contraindications include liver and severe renal failure, hypo- and hyperthyroidism, pregnancy and lactation.

Like any medicine, Vero-Gliclazide may cause side effects. Possible side effects include dyspeptic symptoms (nausea, vomiting, abdominal pain), jaundice, reversible cytopenia, eosinophilia, anemia, allergic skin reactions, photosensitivity, hypoglycemia, weakness, headache, dizziness and changes in taste.

Vero-Gliclazide may interact with some other medicines. ACE inhibitors, anabolic steroids, beta-blockers, fibrates, biguanides, chloramphenicol, cimetidine, coumarins, fenfluramine, fluoxetine, salicylates, guanethidine, MAO inhibitors, miconazole, fluconazole, pentoxifylline, theophylline, phenylbutazone, phosphamides and tetracyclines may increase or enhance hypo glycemic effect Vero-Gliclazide.

The dosage of Vero-Gliclazide should be prescribed by a physician in accordance with the individual characteristics of the patient and the degree of control of blood glucose levels. It is usually recommended to start treatment with a low dose, gradually increasing it if necessary. The drug is taken orally during or immediately after meals.

When using Vero-Gliclazide, it is important to follow your doctor's recommendations, regularly monitor your blood glucose levels, adhere to a diet limited in carbohydrates, and maintain an active lifestyle.

You should consult your doctor or pharmacist for more detailed information about Vero-Gliclazide, its use, possible side effects and interactions with other medicines.